Glucagon: difference between revisions
Diff·revision 10 → 11·08:58, 12 Dec 2024
Difference between revision 10 and revision 11 of Glucagon. 6 lines changed; the page grew by 100 bytes.
| Revision 10 — 14:43, 24 Nov 2024 DulaglutideDug (talk) space between number and unit per PP:MOS 4,787 bytes +590 | Revision 11 — 08:58, 12 Dec 2024 VerifyVesna (talk) ce per PP:MOS 4,887 bytes +100 | ||
|---|---|---|---|
| 42 | <ref name="coskun2022">Coskun T, Urva S, Roell WC, et al. "LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss." ''Cell Metabolism'' 34(9):1234–1247 (2022). DOI:10.1016/j.cmet.2022.07.013. PMID 35985340.</ref> | 42 | <ref name="coskun2022">Coskun T, Urva S, Roell WC, et al. "LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss." ''Cell Metabolism'' 34(9):1234–1247 (2022). DOI:10.1016/j.cmet.2022.07.013. PMID 35985340.</ref> |
| 43 | 43 | ||
| + | 44 | == See also == | |
| + | 45 | * [[Proglucagon]] | |
| + | 46 | * [[Glucagon-like peptide-1]] | |
| + | 47 | * [[Retatrutide]] | |
| + | 48 | * [[Survodutide]] | |
| + | 49 | ||
| 44 | {{DEFAULTSORT:Glucagon}} | 50 | {{DEFAULTSORT:Glucagon}} |
| 45 | [[Category:Peptide drugs]] | 51 | [[Category:Peptide drugs]] |